Beranda › Kanker Paru Non-Sel Kecil › Iowa › Des Moines
Uji klinis Kanker Paru Non-Sel Kecil di Des Moines, IA
11 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Des Moines (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- dan 5 lainnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- dan 5 lainnya
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Menerima pesertaFase 3
- University of Iowa Health Care, Mission Cancer + Blood, Waukee · 14 mi jauhnya
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Des Moines
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Menerima pesertaFase 3
- Clinical Study Site, Waukee · 14 mi jauhnya
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Mission Cancer + Blood - IMMC, Des Moines
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Menerima pesertaFase 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Mercy Medical Center - Des Moines, Des Moines
- dan 4 lainnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Mercy Medical Center - Des Moines, Des Moines
- dan 4 lainnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines
- dan 3 lainnya
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Menerima pesertaFase 2
- Mission Cancer + Blood - Mission Cancer Foundation, Des Moines
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- dan 6 lainnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Des Moines
- Kanker Paru10 studi
- Kanker Payudara8 studi
- Kanker Kolorektal8 studi
- Leukemia Limfositik Kronis8 studi
- Kanker Kandung Kemih6 studi
- Kelebihan Berat Badan6 studi
- Mieloma Multipel5 studi
- Obesitas5 studi
- Leukemia Mieloid Akut5 studi
- Diabetes Tipe 25 studi
- Penyakit Kardiovaskular5 studi
- Limfoma Sel B Besar Difus5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.